Moringa Acquisition Corp

Moringa Acquisition Corp

MACAU
Moringa Acquisition CorpUS flagNASDAQ Capital Market
9.90
USD
-1.90
- -
36.61MMarket Cap
2020 Y
2021 Y
2022 Y
2023 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
- -
- -
- -
Tangible Book Value per Share
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
Net Income, GAAP
- -
-1
1
- -
-1
Effective Tax Rate (%)
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
Working Capital
- -
115
117
6
6
LT Debt
- -
- -
1
3
3
Total Equity
- -
115
115
3
3
Return on Invested Capital (%)
- -
- -
-1.06
-1.82
-2.05
Return on Capital (%)
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
0.51
0.44
-3.78

Capital Structure

FRC

in mil. unless spec.
Dec'23
Mar'24
Jun'24
ST Debt
- -
- -
- -
LT Borrowings
3
3
3
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
4
4
4
Market Capitalization
- -
- -
- -

Working Capital

FRC

in mil. unless spec.
Dec'23
Mar'24
Jun'24
Total Current Assets
6
6
6
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-97.53%
Free Cash Flow
- -
- -
-62.47%
Net Income, GAAP
- -
- -
-54.96%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Ilan Levin
Sector
Financial Services
Industry
Shell Companies
Address
250 Park Avenue New York City NY United States of America 10177
IPO Date
Feb 17, 2021
Business
Moringa Acquisition Corp was formed as a special purpose acquisition company. Its primary goal involved initiating a merger, share exchange, asset acquisition, or similar business combination with an operating entity. The firm initially concentrated on Israeli technology-focused enterprises, later broadening its scope to include the pharmaceutical and biotechnology sectors. In August 2024, it finalized a business combination through a reverse merger with Silexion Therapeutics Ltd., an Israeli clinical-stage oncology biotechnology firm. The combined entity is now known as Silexion Therapeutics Corp, with its shares trading under the ticker SLXN. Established in 2020, the company maintained its principal executive offices in New York, New York.

Company News

APIChat
  • Powering Macau's Smart Future with AI - MACAU Pass and Ant Bank (Macao) Partner with Alibaba Ecosystem to Showcase Smart City Vision at BEYOND Expo

  • Moringa Acquisition (OTCMKTS:MACAU) Shares Down 17.5% – Should You Sell?

  • Moringa Acquisition (OTCMKTS:MACAU) Shares Down 17.5% – Time to Sell?

  • Silexion, a Clinical-Stage, Oncology-Focused Biotechnology Company, to Become Publicly Traded Via Business Combination with Moringa Acquisition Corp

  • MORINGA ACQUISITION CORP ANNOUNCES CONTRIBUTION TO TRUST ACCOUNT IN CONNECTION WITH PROPOSED EXTENSION